Literature DB >> 24939845

Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.

Elizabeth Jaworski1, Aarthi Narayanan1, Rachel Van Duyne2, Shabana Shabbeer-Meyering1, Sergey Iordanskiy2, Mohammed Saifuddin1, Ravi Das1, Philippe V Afonso3, Gavin C Sampey1, Myung Chung1, Anastas Popratiloff4, Bindesh Shrestha5, Mohit Sehgal6, Pooja Jain6, Akos Vertes5, Renaud Mahieux7, Fatah Kashanchi8.   

Abstract

Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical spastic paraparesis. The HTLV-1 transactivator protein Tax controls many critical cellular pathways, including host cell DNA damage response mechanisms, cell cycle progression, and apoptosis. Extracellular vesicles called exosomes play critical roles during pathogenic viral infections as delivery vehicles for host and viral components, including proteins, mRNA, and microRNA. We hypothesized that exosomes derived from HTLV-1-infected cells contain unique host and viral proteins that may contribute to HTLV-1-induced pathogenesis. We found exosomes derived from infected cells to contain Tax protein and proinflammatory mediators as well as viral mRNA transcripts, including Tax, HBZ, and Env. Furthermore, we observed that exosomes released from HTLV-1-infected Tax-expressing cells contributed to enhanced survival of exosome-recipient cells when treated with Fas antibody. This survival was cFLIP-dependent, with Tax showing induction of NF-κB in exosome-recipient cells. Finally, IL-2-dependent CTLL-2 cells that received Tax-containing exosomes were protected from apoptosis through activation of AKT. Similar experiments with primary cultures showed protection and survival of peripheral blood mononuclear cells even in the absence of phytohemagglutinin/IL-2. Surviving cells contained more phosphorylated Rb, consistent with the role of Tax in regulation of the cell cycle. Collectively, these results suggest that exosomes may play an important role in extracellular delivery of functional HTLV-1 proteins and mRNA to recipient cells.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Biomarker; Cytokine Induction; Exosome; HTLV-1 Infection; Leukemia; Oncogene; Tax Protein; Transactivation

Mesh:

Substances:

Year:  2014        PMID: 24939845      PMCID: PMC4139239          DOI: 10.1074/jbc.M114.549659

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  134 in total

1.  Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.

Authors:  Jingga Inlora; Vineela Chukkapalli; David Derse; Akira Ono
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Cytokine production by endothelial cells infected with human T cell lymphotropic virus type I.

Authors:  H Takashima; K Eguchi; A Kawakami; Y Kawabe; K Migita; M Sakai; T Origuchi; S Nagataki
Journal:  Ann Rheum Dis       Date:  1996-09       Impact factor: 19.103

3.  Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells.

Authors:  Melissa K Callahan; Paul M Popernack; Shigeki Tsutsui; Linh Truong; Robert A Schlegel; Andrew J Henderson
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

4.  Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.

Authors:  Anja Honegger; Jenny Leitz; Julia Bulkescher; Karin Hoppe-Seyler; Felix Hoppe-Seyler
Journal:  Int J Cancer       Date:  2013-04-30       Impact factor: 7.396

5.  Human T-cell leukemia virus type 1 infection leads to arrest in the G1 phase of the cell cycle.

Authors:  Meihong Liu; Liangpeng Yang; Ling Zhang; Baoying Liu; Randall Merling; Zheng Xia; Chou-Zen Giam
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

6.  Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells.

Authors:  P F Lindholm; R L Reid; J N Brady
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  High production of RANTES and MIP-1alpha in the tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).

Authors:  Patricia Montanheiro; Maria Paulina Posada Vergara; Jerusa Smid; Alberto José da Silva Duarte; Augusto César Penalva de Oliveira; Jorge Casseb
Journal:  J Neuroimmunol       Date:  2007-06-22       Impact factor: 3.478

8.  Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes.

Authors:  Simona Ceccarelli; Vincenzo Visco; Salvatore Raffa; Naohiro Wakisaka; Joseph S Pagano; Maria Rosaria Torrisi
Journal:  Int J Cancer       Date:  2007-10-01       Impact factor: 7.396

9.  Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction.

Authors:  G Hu; H Yao; A D Chaudhuri; M Duan; S V Yelamanchili; H Wen; P D Cheney; H S Fox; S Buch
Journal:  Cell Death Dis       Date:  2012-08-30       Impact factor: 8.469

Review 10.  Exosomes: vesicular carriers for intercellular communication in neurodegenerative disorders.

Authors:  Anja Schneider; Mikael Simons
Journal:  Cell Tissue Res       Date:  2012-05-19       Impact factor: 5.249

View more
  65 in total

Review 1.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

Review 2.  Exosomes in Viral Disease.

Authors:  Monique R Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

Review 3.  Extracellular Vesicles Exploit Viral Entry Routes for Cargo Delivery.

Authors:  Helena M van Dongen; Niala Masoumi; Kenneth W Witwer; D Michiel Pegtel
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-02       Impact factor: 11.056

4.  Exosomes from uninfected cells activate transcription of latent HIV-1.

Authors:  Robert A Barclay; Angela Schwab; Catherine DeMarino; Yao Akpamagbo; Benjamin Lepene; Seble Kassaye; Sergey Iordanskiy; Fatah Kashanchi
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 5.  Extracellular vesicles are the Trojan horses of viral infection.

Authors:  Nihal Altan-Bonnet
Journal:  Curr Opin Microbiol       Date:  2016-05-24       Impact factor: 7.934

6.  Dynamic acquisition of HTLV-1 tax protein by mononuclear phagocytes: Role in neurologic disease.

Authors:  Eiji Matsuura; Yoshimi Enose-Akahata; Karen Yao; Unsong Oh; Yuetsu Tanaka; Hiroshi Takashima; Steven Jacobson
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

Review 7.  The Role of Exosomal VP40 in Ebola Virus Disease.

Authors:  Michelle L Pleet; Catherine DeMarino; Benjamin Lepene; M Javad Aman; Fatah Kashanchi
Journal:  DNA Cell Biol       Date:  2017-02-08       Impact factor: 3.311

8.  Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes.

Authors:  Yu Zhou; Xu Wang; Li Sun; Li Zhou; Tong-Cui Ma; Li Song; Jian-Guo Wu; Jie-Liang Li; Wen-Zhe Ho
Journal:  FASEB J       Date:  2016-09-07       Impact factor: 5.191

Review 9.  Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.

Authors:  Hélène Dutartre; Mathieu Clavière; Chloé Journo; Renaud Mahieux
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

10.  In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.

Authors:  Ria Mulherkar; Aykan Karabudak; Rashida Ginwala; Xiaofang Huang; Aileen Rowan; Ramila Philip; Edward L Murphy; Danielle Clements; Lishomwa C Ndhlovu; Zafar K Khan; Pooja Jain
Journal:  Vaccine       Date:  2018-07-10       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.